返回 Agenda
Major Pharmacovigilance Decisions: The Trend in the Evidence Used And Measuring their Impact
Speaker(s)
Considerations about Benefits-Risks Linked to the Patient Voice
Saad Shakir, DrMed, MD, FFPM, FISPE, FRCP
Drug Safety Research Unit, United Kingdom
Director